Patients receiving this ligand on the day of transplantation exhibited improved reconstitution of Helios+ Treg cells (defined as higher than 12% of CD4+ cells at any timepoint after allo-HCT) and lower incidence of grade 2–4 acute GVHD (171). This evidence concerns the gene CD4 and acute graft versus host disease.